박셀바이오

323990KOSDAQ자연과학 및 공학 연구개발업

56.3 / 100

Reference Date: 2026-07-24

Financial Score21.0 / 40

News Sentiment21.3 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Operating Profit is on a declining trend. Declined 6.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Parkcell Bio is a biotech company specializing in cancer immunotherapy, developing various platforms such as Vax-NK and Vax-CAR for immune cell therapies and targeted anticancer drugs. It also expands its pet healthcare business through its veterinary immunomodulatory drug 'Vaxleukin-15' and has enhanced its commercialization capabilities by constructing an advanced manufacturing platform following the completion of its new headquarters in 2025.

Number of Employees

91people

Average Salary

49.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

1.56Industry Average 2.525.5Point

Lower than industry avg (good)

ROE

-20.04Industry Average -32.093.5Point

Below industry avg

Debt Ratio

3.69Industry Average 7.315.0Point

Lower than industry avg (good)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲7004.4% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼16.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -17.7% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
차세대 신약개발 협력 본격화…아이티아이즈 상한가[특징주]
아이티아이즈의 차세대 바이오 AI 시장 진출 소식으로 박셀바이오와 직접적인 연관성이 없으나, 관련 산업의 성장 기대감으로 인해 박셀바이오의 긍정적인 시장 분위기가 반영됨.
Positive
박셀바이오, 아이티아이즈와 AI 기반 차세대 세포·유전자치료제 개발.....
박셀바이오와 아이티아이즈의 MOU 체결로 AI 기반 차세대 CGT 및 항암면역치료제 개발이 가속화되어 긍정적인 시장 반응 예상.
Positive
아이티아이즈-박셀바이오, AI 기반 차세대 신약개발 협력 본격화
AI 기술 협력으로 박셀바이오의 신약 개발 경쟁력이 강화되어 긍정적인 시장 반응 예상.

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 4,095Won52-week high 11,00052-week low 3,860

1-month return2.0Point

1m -6.83% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0